Briquet, C., Artoisenet, C., Coen, M., De Groot, A., Gillard, N., Honoré, A., Jacquet, S., Paque, C., Pardo, A., Vandamme, N., Van den Berg, V., Van Wetter, C., & Vercheval, C. (July 2021). Antimicrobial Stewardship Programs in 13 Belgian hospitals: a survey from the french association of belgian hospital pharmacists [Poster presentation]. 31st ECCMID. |
FONTAINE, C., Catarin, N., MEEX, C., Vercheval, C., MACLOT, F., HAYETTE, M.-P., & DESCY, J. (July 2021). Clinical impact of a direct Rapid Antimicrobial Susceptibility Testing (dRAST) in administration of optimal therapy in patients with bloodstream infection [Poster presentation]. ECCMID. |
Lambert, N., Hansen, I., El Moussaoui, M., GIOT, J.-B., Vercheval, C., LOMMERS, E., SOMJA, J., MOUTSCHEN, M., & MAQUET, P. (2021). Lung and liver sarcoidosis‐like reaction induced by tocilizumab. British Journal of Clinical Pharmacology. doi:10.1111/bcp.14878 Peer Reviewed verified by ORBi |
Vercheval, C., Sadzot, B., MAES, N., Denooz, R., Damas, P., & FRIPPIAT, F. (2021). Continuous infusion of cefepime and neurotoxicity: a retrospective cohort study. Clinical Microbiology and Infection. doi:10.1016/j.cmi.2020.07.003 Peer Reviewed verified by ORBi |
Vercheval, C. (2020). Contribution d’un pharmacien clinicien spécialisé en maladies infectieuses dans un programme de gestion des anti-infectieux [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/315173 |
FRIPPIAT, F., Vercheval, C., & Layios, N. (2020). Meropenem: continuous or extended infusion? Critical care (London, England), 24 (1), 192. doi:10.1186/s13054-020-02883-w Peer reviewed |
El Moussaoui, M., Lambert, I., MAES, N., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., Fombellida, K., VAIRA, D., Vercheval, C., Moutschen, M., & Darcis, G. (2020). Evolution of Drug Interactions With Antiretroviral Medication in People With HIV. Open Forum Infectious Diseases, 7 (11), 416. doi:10.1093/ofid/ofaa416 Peer Reviewed verified by ORBi |
Vercheval, C., DAMAS, P., & FRIPPIAT, F. (2020). Quality of documentation on antibiotic treatment in medical records: evaluation of the long-term impact of an antimicrobial stewardship intervention [Poster presentation]. 30th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Paris, France. |
El Moussaoui, M., Lambert, I., MAES, N., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., FOMBELLIDA, K., VAIRA, D., Vercheval, C., MOUTSCHEN, M., & DARCIS, G. (22 November 2019). Evolution of drug interactions with antiretroviral medications in HIV-infected patients [Poster presentation]. 8th BREACH SYMPOSIUM, Liège, Belgium. |
El Moussaoui, M., Lambert, I., MAES, N., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., Fombellida, K., VAIRA, D., Vercheval, C., MOUTSCHEN, M., & DARCIS, G. (08 November 2019). Evolution of drug interactions with antiretroviral medications in HIV-infected patients [Paper presentation]. 17th European AIDS Conference, Bâle, Switzerland. |
Vercheval, C., GILLET, M., Koch, N., HAYETTE, M.-P., FRIPPIAT, F., DAMAS, P., & VAN HEES, T. (2019). Utilisation de la nystatine dans la candidose oropharyngée au CHU de Liège. Journal de Pharmacie de Belgique. Peer Reviewed verified by ORBi |
STREEL, S., Vercheval, C., Servais, A.-C., Fillet, M., & Van Hees, T. (24 February 2018). Stability of 90 mg/ml cefuroxime sodium solution for administration by continuous infusion [Poster presentation]. Assemble Générale de l'Association Francophone des Pharmaciens Hospitaliers de Belgique, Mons, Belgium. |
Vercheval, C., STREEL, S., Servais, A.-C., Fillet, M., & Van Hees, T. (2018). Stability of 90 mg/mL cefuroxime sodium solution for administration by continuous infusion. Journal of Chemotherapy, 30 (6-8), 371-374. doi:10.1080/1120009X.2018.1535950 Peer Reviewed verified by ORBi |
FRIPPIAT, F., VERCHEVAL, C., & LAYIOS, N. (01 February 2016). Decreased antibiotic consumption in the Belgian community: Is it credible? Clinical Infectious Diseases, 62 (3), 403-404. doi:10.1093/cid/civ868 Peer Reviewed verified by ORBi |
VERCHEVAL, C., GILLET, M., MAES, N., Albert, A., FRIPPIAT, F., Damas, P., & Van Hees, T. (2016). Quality of documentation on antibiotic therapy in medical records: evaluation of combined interventions in a teaching hospital by repeated point prevalence survey. European Journal of Clinical Microbiology and Infectious Diseases, 35 (9), 1495–1500. doi:10.1007/s10096-016-2690-0 Peer Reviewed verified by ORBi |
DAMAS, M., Vercheval, C., NYS, M., LAMBERMONT, B., ANCION, A., & DAMAS, P. (October 2015). Use of beta-lactams antibiotics in ICU patients [Poster presentation]. ESICM LIVES, Berlin, Germany. |
Van Hees, T., & VERCHEVAL, C. (2014). Système Informatisé d’Aide à la Décision (SIAD) : Opportunité pour le GGA ? [Paper presentation]. Mardi Midi de l'Infectiologie, Liège, Belgium. |
VERCHEVAL, C., DAMAS, P., & Van Hees, T. (02 March 2013). Du simple audit à l’amélioration continue de la qualité des pratiques dans le domaine de l’antibiothérapie [Poster presentation]. 24ème journée de l'Association Francophone des Pharmaciens Hospitaliers de Belgique, La Hulpe, Belgium. |
VERCHEVAL, C., Van Hees, T., & DAMAS, P. (2013). From point prevalence surveys to continuous quality improvement in a teaching hospital in Belgium [Poster presentation]. 23rd ECCMID, Berlin, Germany. |
FRIPPIAT, F., VERCHEVAL, C., LAMBERMONT, B., & DAMAS, P. (2013). Is extended or continuous infusion of Carbapenems the obvious solution to improve clinical outcomes and reduce mortality? Clinical Infectious Diseases, 57 (2), 324-325. doi:10.1093/cid/cit205 Peer Reviewed verified by ORBi |
ANCION, A., LAYIOS, N., NYS, M., VERCHEVAL, C., & DAMAS, P. (2012). Antibiotic therapy and outcome in ICU [Paper presentation]. Congrès de la SIZ. |
LEGRAIN, C., VERCHEVAL, C., NYS, M., MATHY, X., & DAMAS, P. (2012). Adaptation des traitements antibiotiques après 72 heures lors d'infection acquise en USI. Réanimation, 22 (Suppl 2), 250 (SPF033. Peer Reviewed verified by ORBi |